e-learning
resources
Amsterdam 2015
Wednesday, 30.09.2015
Inhaled drugs: within and beyond the lungs
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Delivering inhaled drugs to the small airways - Does it matter?
O.S. Usmani (London, United Kingdom)
Source:
International Congress 2015 – Inhaled drugs: within and beyond the lungs
Session:
Inhaled drugs: within and beyond the lungs
Session type:
Symposium
Number:
4942
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O.S. Usmani (London, United Kingdom). Delivering inhaled drugs to the small airways - Does it matter?. International Congress 2015 – Inhaled drugs: within and beyond the lungs
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Targeting small airways in asthma: the new challenge of inhaled corticosteroid treatment
Source: Eur Respir J 2008; 31: 1145-1147
Year: 2008
It does matter which inhalative corticosteroids asthmatic patient use! Looking at ICS side effects from users perspective
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008
Acute effects of bronchial thermoplasty: a matter of concern or an indicator of possible benefit to small airways?
Source: Eur Respir J , 49 (3) 1700029; DOI: 10.1183/13993003.00029-2017
Year: 2017
Extent of inhaled drug deposition in mouth-throat and pulmonary airways: A novel biophysical modelling approach for inhaled therapeutics
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
Is there room for further innovation in inhaled therapy for airways disease?
Source: Breathe, 14 (3) 216; 10.1183/20734735.020318
Year: 2018
Inhaled therapies: can they breathe new life into asthma?
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019
Is there a problem with inhaled corticosteroid use in COPD?
Source: Virtual Congress 2020 – Airway diseases
Year: 2020
Particle size matters: diagnostics and treatment of small airways involvement in asthma
Source: Eur Respir J 2011; 37: 532-540
Year: 2011
What to use INSTEAD of inhaled corticosteroids in COPD?
Source: Eur Respir J 2014; 44: 1391-1393
Year: 2014
Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation
Source: Eur Respir J 2011; 38: 1328-1335
Year: 2011
Improvement of small airway deposition of corticosteroids by smart nebulisation
Source: International Congress 2018 – Asthma and drugs
Year: 2018
Assessing regional airways responses to inhaled bronchodilators in asthmatics
Source: Annual Congress 2010 - Airways mechanics in different applications
Year: 2010
Small airway function in asthma patients treated with an ultrafine inhaled steroid aerosol
Source: Eur Respir J 2004; 24: Suppl. 48, 581s
Year: 2004
Small airways targeting of inhaled steroids for severe therapy resistant asthma in children
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015
What the pulmonary specialist should know about the new inhalation therapies
Source: Eur Respir J 2011; 37: 1308-1417
Year: 2011
Knowing when to stop: inhaled corticosteroids and COPD
Source: Eur Respir J 2015; 46: 1236-1238
Year: 2015
Inhaled corticosteroids in preschool asthmatics: are they effective and who benefits most?
Source: Eur Respir J 2003; 22: Suppl. 45, 534s
Year: 2003
Monitoring asthma: no matter how?
Source: Eur Respir J 2016; 48: 614-616
Year: 2016
Expanding role of aerosols: systemic drug delivery, gene therapy and vaccination
Source: Annual Congress 2007 - ISAM - Expanding role of aerosols: systemic drug delivery, gene therapy and vaccination
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept